Outcomes in Antiplatelet‐Associated Intracerebral Hemorrhage in the TICH‐2 Randomized Controlled Trial

BACKGROUND: Antiplatelet therapy increases the risk of hematoma expansion in intracerebral hemorrhage (ICH) while the effect on functional outcome is uncertain. METHODS AND RESULTS: This is an exploratory analysis of the TICH‐2 (Tranexamic Acid in Intracerebral Hemorrhage‐2) double‐blind, randomized...

Descripción completa

Detalles Bibliográficos
Autores principales: Law, Zhe Kang, Desborough, Michael, Roberts, Ian, Al‐Shahi Salman, Rustam, England, Timothy J., Werring, David J., Robinson, Thompson, Krishnan, Kailash, Dineen, Robert, Laska, Ann Charlotte, Peters, Nils, Egea‐Guerrero, Juan Jose, Karlinski, Michal, Christensen, Hanne, Roffe, Christine, Bereczki, Daniel, Ozturk, Serefnur, Thanabalan, Jegan, Collins, Rónán, Beridze, Maia, Bath, Philip M., Sprigg, Nikola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174262/
https://www.ncbi.nlm.nih.gov/pubmed/33586453
http://dx.doi.org/10.1161/JAHA.120.019130

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174262/
https://www.ncbi.nlm.nih.gov/pubmed/33586453
http://dx.doi.org/10.1161/JAHA.120.019130

Ejemplares similares